Trending Now
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply...
The commonwealth government of Australia awarded an order worth $5 million to OSI Systems, Inc. (NASDAQ:OSIS). As per the terms of the contract, OSI’s...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Inovio Pharmaceuticals Inc (NASDAQ:INO) Receives Funding From DOD And DARPA To...
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced the receipt of funding from DOD (Department of Defense) and DARPA (Defense Advanced Research Projects Agency) to develop dMAb.
Preventive...
MAKE IT MODERN
LATEST REVIEWS
Plus Therapeutics Inc. (NASDAQ: PSTV) Announce Master Service Agreement For 186RNL...
Plus Therapeutics Inc. (NASDAQ: PSTV) has announced that it has attained two significant milestones as it advances towards current Good Manufacturing Practices (cGMP) production...
MAKE IT MODERN
PERFORMANCE TRAINING
Erytech Pharma SA (NASDAQ: ERYP) and Catalent Inc (NYSE: CTLT) Execute an Agreement for...
Erytech Pharma SA (NASDAQ: ERYP) and Catalent Inc (NYSE: CTLT) recently executed an agreement to purchase Erytech's manufacturing plant located in New Jersey for...
2022 is Turning into the Year of the Energy Stock Boom (HAL, VKIN, SLB,...
Unless you’ve been living under a rock for the past 6 weeks, you are painfully aware of recent events in eastern Europe....
Inhibikase Therapeutics Inc. (NASDAQ: IKT) Publishes Study Showing Oral c-Abl Kinase Inhibitor’s Potential Ion...
Inhibikase Therapeutics Inc. (NASDAQ: IKT) has announced a publication detailing the biochemical rationale and possible benefits of Abelson Tyrosine kinase inhibition as a possible...
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) Announce Expanded Access Protocol For IOTs Mino-Lok Solution
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) has announced that it will offer healthcare providers free access to its Mino-Lok under an Expanded Access program as a...
Spotlight on Delivery Stocks as Omicron Takes Center Stage (DELHY, TWOH, UBER, GRUB, LYFT,...
As the Omicron variant starts to take over the headline feed around Covid, investors are left with the need to diversify back...
MAKE IT MODERN
